Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUSÂ platform to develop in vivo gene editi

--Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings-- --Randomized, Double-Blind, Placebo-Controlled HOPE-3 Phase 3 Trial (n=106) Met Primary Endpoint, with Deramiocel Slowing Upper Limb Function Decline by 54 Percent versus Placebo (PUL 2.0, p=0.03) and Showing Clinically Meaningful Cardiac Benefit--

Hope Bancorp delivered a strong Q2 2026, with revenue and adjusted EPS both exceeding analyst expectations and a swing from loss to profit. HOPE's net interest margin expanded to 2.96%, deposits and loans grew, and non-interest income rebounded sharply due to the absence of prior-year securities losses. Despite trading below book value, HOPE's forward P/E of 13.8 and subpar asset quality (ROA 0.71%, ROE 5.76%) limit its attractiveness.

NEW YORK--(BUSINESS WIRE)--Bank of Hope, subsidiary of Hope Bancorp, Inc. (NASDAQ: HOPE), is expanding the ways it connects with customers and community members through a creative branding campaign centered on a sponsorship of 'BTS THE CITY ARIRANG NEW YORK'. Celebrating ‘BTS THE CITY ARIRANG NEW YORK' as people from around the world gather in New York City, this campaign serves as a unique activation targeted at today's consumers who seek meaningful relationships with the brands with which the.

Hope Bancorp, Inc. (HOPE) Q2 2026 Earnings Call Transcript

Hope Bancorp NASDAQ: HOPE reported higher second-quarter earnings and revenue as net interest margin expanded, loan growth accelerated and the company continued to improve its deposit mix ahead of its planned acquisition of SMBC MANUBANK's commercial banking unit.

While the top- and bottom-line numbers for Hope Bancorp (HOPE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Hope Bancorp (HOPE) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.19 per share a year ago.

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (the “Company”) (NASDAQ: HOPE) today announced that its Board of Directors declared a quarterly cash dividend of $0.14 per common share. The dividend is payable on or about August 20, 2026, to all stockholders of record as of the close of business on August 6, 2026.About Hope Bancorp, Inc.Hope Bancorp, Inc. (NASDAQ: HOPE) is the holding company for Bank of Hope, with $18.99 billion in total assets as of June 30, 2026. Following the addition of Ter.

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (the “Company”) (NASDAQ: HOPE), the holding company of Bank of Hope (the “Bank”), today reported unaudited financial results for its second quarter and six months ended June 30, 2026. For the second quarter of 2026, the Company reported net income of $33.0 million, or $0.26 per diluted common share, up 12% from net income of $29.5 million, or $0.23 per diluted common share, for the first quarter of 2026, and up from a net loss of $24.8 million, o.